Jubilant Revenues Flat On LSI Decline
LSI Business To Be Demerged As Part Of Restructuring
Executive Summary
Jubilant reports higher second-quarter profits as it defers tax liability while revenues remain flat on the back of a decline in the LSI business and FDA action at two manufacturing units.